Reviews Soliris


No reviews yet.

Soliris Drug Description
Soliris™
(eculizumab)

WARNING: SERIOUS MENINGOCOCCAL INFECTION
Soliris increases the risk of meningococcal infections


Vaccinate patients with a meningococcal
vaccine at least 2 weeks prior to receiving the first dose of Soliris; revaccinate
according to current medical guidelines for vaccine use


Monitor patients for early signs of meningococcal
infections, evaluate immediately if infection is suspected, and treat with
antibiotics if necessary.



DRUG DESCRIPTION



What are the possible side effects of eculizumab (Soliris)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

severe headache with fever, confusion, skin rash, and nausea or vomiting;
stiffness in your neck or back;
sensitivity to bright light;
high fever (103 degrees or higher), chills, body aches, flu symptoms;
any signs of a...
Read All Potential Side Effects for Soliris »




Soliris is a formulation of eculizumab which is a recombinant humanized monoclonal IgG2/4;κ antibody produced by murine myeloma cell culture and purified by standard bioprocess technology. Eculizumab contains human constant regions from human IgG2 sequences and human IgG4 sequences and murine complementarity-determining regions grafted onto the human framework light- and heavy-chain variable regions. Eculizumab is composed of two 448 amino acid heavy chains and two 214 amino acid light chains and has a molecular weight of approximately 148 kDa.
Soliris is a sterile, clear, colorless, preservative-free 10 mg/mL solution for intravenous infusion and is supplied in 30-mL single-use vials. The product is formulated at pH 7 and each vial contains 300 mg of eculizumab, 13.8 mg sodium phosphate monobasic, 53.4 mg sodium phosphate dibasic, 263.1 mg sodium chloride, 6.6 mg polysorbate 80 (vegetable origin) and Water for Injection, USP.Last reviewed on RxList: 4/5/2007




Soliris Drug Description
Soliris™
(eculizumab)

WARNING: SERIOUS MENINGOCOCCAL INFECTION
Soliris increases the risk of meningococcal infections


Vaccinate patients with a meningococcal
vaccine at least 2 weeks prior to receiving the first dose of Soliris; revaccinate
according to current medical guidelines for vaccine use


Monitor patients for early signs of meningococcal
infections, evaluate immediately if infection is suspected, and treat with
antibiotics if necessary.



DRUG DESCRIPTION



What are the possible side effects of eculizumab (Soliris)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

severe headache with fever, confusion, skin rash, and nausea or vomiting;
stiffness in your neck or back;
sensitivity to bright light;
high fever (103 degrees or higher), chills, body aches, flu symptoms;
any signs of a...
Read All Potential Side Effects for Soliris »




Soliris is a formulation of eculizumab which is a recombinant humanized monoclonal IgG2/4;κ antibody produced by murine myeloma cell culture and purified by standard bioprocess technology. Eculizumab contains human constant regions from human IgG2 sequences and human IgG4 sequences and murine complementarity-determining regions grafted onto the human framework light- and heavy-chain variable regions. Eculizumab is composed of two 448 amino acid heavy chains and two 214 amino acid light chains and has a molecular weight of approximately 148 kDa.
Soliris is a sterile, clear, colorless, preservative-free 10 mg/mL solution for intravenous infusion and is supplied in 30-mL single-use vials. The product is formulated at pH 7 and each vial contains 300 mg of eculizumab, 13.8 mg sodium phosphate monobasic, 53.4 mg sodium phosphate dibasic, 263.1 mg sodium chloride, 6.6 mg polysorbate 80 (vegetable origin) and Water for Injection, USP.Last reviewed on RxList: 4/5/2007




Soliris Drug Description
Soliris™
(eculizumab)

WARNING: SERIOUS MENINGOCOCCAL INFECTION
Soliris increases the risk of meningococcal infections


Vaccinate patients with a meningococcal
vaccine at least 2 weeks prior to receiving the first dose of Soliris; revaccinate
according to current medical guidelines for vaccine use


Monitor patients for early signs of meningococcal
infections, evaluate immediately if infection is suspected, and treat with
antibiotics if necessary.



DRUG DESCRIPTION



What are the possible side effects of eculizumab (Soliris)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

severe headache with fever, confusion, skin rash, and nausea or vomiting;
stiffness in your neck or back;
sensitivity to bright light;
high fever (103 degrees or higher), chills, body aches, flu symptoms;
any signs of a...
Read All Potential Side Effects for Soliris »




Soliris is a formulation of eculizumab which is a recombinant humanized monoclonal IgG2/4;κ antibody produced by murine myeloma cell culture and purified by standard bioprocess technology. Eculizumab contains human constant regions from human IgG2 sequences and human IgG4 sequences and murine complementarity-determining regions grafted onto the human framework light- and heavy-chain variable regions. Eculizumab is composed of two 448 amino acid heavy chains and two 214 amino acid light chains and has a molecular weight of approximately 148 kDa.
Soliris is a sterile, clear, colorless, preservative-free 10 mg/mL solution for intravenous infusion and is supplied in 30-mL single-use vials. The product is formulated at pH 7 and each vial contains 300 mg of eculizumab, 13.8 mg sodium phosphate monobasic, 53.4 mg sodium phosphate dibasic, 263.1 mg sodium chloride, 6.6 mg polysorbate 80 (vegetable origin) and Water for Injection, USP.Last reviewed on RxList: 4/5/2007




Soliris Drug Description
Soliris™
(eculizumab)

WARNING: SERIOUS MENINGOCOCCAL INFECTION
Soliris increases the risk of meningococcal infections


Vaccinate patients with a meningococcal
vaccine at least 2 weeks prior to receiving the first dose of Soliris; revaccinate
according to current medical guidelines for vaccine use


Monitor patients for early signs of meningococcal
infections, evaluate immediately if infection is suspected, and treat with
antibiotics if necessary.



DRUG DESCRIPTION



What are the possible side effects of eculizumab (Soliris)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

severe headache with fever, confusion, skin rash, and nausea or vomiting;
stiffness in your neck or back;
sensitivity to bright light;
high fever (103 degrees or higher), chills, body aches, flu symptoms;
any signs of a...
Read All Potential Side Effects for Soliris »




Soliris is a formulation of eculizumab which is a recombinant humanized monoclonal IgG2/4;κ antibody produced by murine myeloma cell culture and purified by standard bioprocess technology. Eculizumab contains human constant regions from human IgG2 sequences and human IgG4 sequences and murine complementarity-determining regions grafted onto the human framework light- and heavy-chain variable regions. Eculizumab is composed of two 448 amino acid heavy chains and two 214 amino acid light chains and has a molecular weight of approximately 148 kDa.
Soliris is a sterile, clear, colorless, preservative-free 10 mg/mL solution for intravenous infusion and is supplied in 30-mL single-use vials. The product is formulated at pH 7 and each vial contains 300 mg of eculizumab, 13.8 mg sodium phosphate monobasic, 53.4 mg sodium phosphate dibasic, 263.1 mg sodium chloride, 6.6 mg polysorbate 80 (vegetable origin) and Water for Injection, USP.Last reviewed on RxList: 4/5/2007




Soliris Drug Description
Soliris™
(eculizumab)

WARNING: SERIOUS MENINGOCOCCAL INFECTION
Soliris increases the risk of meningococcal infections


Vaccinate patients with a meningococcal
vaccine at least 2 weeks prior to receiving the first dose of Soliris; revaccinate
according to current medical guidelines for vaccine use


Monitor patients for early signs of meningococcal
infections, evaluate immediately if infection is suspected, and treat with
antibiotics if necessary.



DRUG DESCRIPTION



What are the possible side effects of eculizumab (Soliris)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:

severe headache with fever, confusion, skin rash, and nausea or vomiting;
stiffness in your neck or back;
sensitivity to bright light;
high fever (103 degrees or higher), chills, body aches, flu symptoms;
any signs of a...
Read All Potential Side Effects for Soliris »




Soliris is a formulation of eculizumab which is a recombinant humanized monoclonal IgG2/4;κ antibody produced by murine myeloma cell culture and purified by standard bioprocess technology. Eculizumab contains human constant regions from human IgG2 sequences and human IgG4 sequences and murine complementarity-determining regions grafted onto the human framework light- and heavy-chain variable regions. Eculizumab is composed of two 448 amino acid heavy chains and two 214 amino acid light chains and has a molecular weight of approximately 148 kDa.
Soliris is a sterile, clear, colorless, preservative-free 10 mg/mL solution for intravenous infusion and is supplied in 30-mL single-use vials. The product is formulated at pH 7 and each vial contains 300 mg of eculizumab, 13.8 mg sodium phosphate monobasic, 53.4 mg sodium phosphate dibasic, 263.1 mg sodium chloride, 6.6 mg polysorbate 80 (vegetable origin) and Water for Injection, USP.Last reviewed on RxList: 4/5/2007





Other reviews about Soliris on wordpress

Soliris and Sucking it Up
  by Day
After months of what seemed to be an endless rollercoaster of indecision (admittedly, some on my part) and bureaucracy, I am finally almost ready to start Soliris, the […]


Interview with Alexion CEO Leonard Bell
  by Carl Mercurio
Drugs to treat rare and often costly diseases have been among the biggest breakthroughs in the biotech and pharmaceutical field.┬á In this video interview, Leonard Bell, M.D., chief […]


New England Journal Of Medicine Publishes Case Reports On The Investigational Use Of Soliris(R) In Patients With Atypical Hemolytic Uremic Syndrome
  by yestelli
Two separate case reports published in the New England Journal of Medicine (NEJM) examine the investigational use of Soliris ┬« (eculizumab), a terminal complement inhibitor developed by Alexion […]


Alexion’s Soliris(R) (eculizumab) Receives Marketing Approval In Australia For All Patients With PNH
  by maciekmaciek5
Alexion Pharmaceuticals, Inc., (Nasdaq:ALXN) announced that the Australian Government's Therapeutic Goods Administration has approved the use of Soliris┬« (eculizumab) for the treatment of all patients in Australia with […]


Alexion’s Soliris(R) (eculizumab) Receives Marketing Approval In Australia For All Patients With PNH
  by maciekmaciek5
Alexion Pharmaceuticals, Inc., (Nasdaq:ALXN) announced that the Australian Government's Therapeutic Goods Administration has approved the use of Soliris┬« (eculizumab) for the treatment of all patients in Australia with […]


Music Affiliatez
  by Z
G Brown @ djgbrown.com Soliris @ myspace.com/solirismusic Rugged N Raw @ myspace.com/ruggednrawrnr Michal Towber @ facebook.com/michaltowber Dujeous @ www.dujeous.net Black Skeptik @ myspace.com/blackskeptik The Analogy @ myspace.com/theanalogynyc Konspiracy Theory Music @ myspace.com/konspiracy7theory Lizzy Grant @ lizzygrant.com Z [also @ facebook.com/ztheprince, myspace.com/ztheprince, twitter.com/ztheprince]


The world's most expensive drugs
  by Carolyn Thomas
┬á When people talk about expensive drugs, they usually are referring to drugs like Lipitor for high cholesterol ($1,500 a year), Zyprexa for schizophrenia ($7,000 a year) or Avastin […]


Nassim Haramein y Marco Rodin, una nueva visi├│n del universo
  by trinityatierra
Nassim Haramein y Marco Rodin traducidos en voz por la Fundaci├│n Soliris [youtube=http://www.youtube.com/watch?v=bw1uJNAKYWQ&feature=related] [youtube=http://www.youtube.com/watch?v=DWOGJtszBB0&feature=related] [youtube=http://www.youtube.com/watch?v=HlXZ7lzxNBE&feature=related] [youtube=http://www.youtube.com/watch?v=LZZs6ZZa5Sg&feature=related]



Other reviews about Soliris on web:

Soliris.net provides information on Soliris, is the first therapy specifically indicated to reduce hemolysis in all patients with paroxysmal nocturnal hemoglobinuria - PNH. Soliris - FDA-Approved Treatment for PNH Disease | Soliris.net


Soliris (eculizumab) prevents the breakdown of red blood cells in people with paroxysmal nocturnal hemoglobinemia. Includes Soliris side effects, interactions and indications. Soliris Information from Drugs.com


Learn about the prescription medication Soliris (Eculizumab), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Soliris (Eculizumab) Drug Information: Uses, Side Effects, Drug ...


Soliris is administered through an intravenous infusion. The infusion must be prepared and administered by a qualified, licensed healthcare professional, usually at a healthcare ... Soliris Dosing and Administration Guide


All about Soliris. View complete and up to date Soliris information - part of the Drugs.com trusted medication database. Soliris Facts and Comparisons at Drugs.com


Eculizumab (INN and USAN, trade name Soliris) is a monoclonal antibody directed against the complement protein C5. This antibody blocks the cleavage of C5 and halts the process of ... Eculizumab - Wikipedia, the free encyclopedia


Soliris is approved for the treatment of patients with PNH. Soliris is the only treatment for PNH that reduces hemolysis. Alexion Pharmaceuticals - Soliris & PNH


What is Soliris (Eculizumab)? Eculizumab is a monoclonal antibody that binds to proteins in the blood that can destroy red blood cells in people with a genetic condition that ... Soliris - Drugs & Treatments - Revolution Health


Solaris is a Unix operating system originally developed by Sun Microsystems. It superseded their earlier SunOS in 1992. Oracle Solaris, as it is now known, has been owned by Oracle ... Solaris (operating system) - Wikipedia, the free encyclopedia


Discovered, developed and marketed exclusively by Alexion, Soliris is the first and only approved medication that blocks complement and reduces hemolysis in patients with PNH Alexion Pharmaceuticals - About Soliris





Featured Reviews

Reviews Thiopental Sodium

Pentothal Drug Description Pentothal (thiopental sodium) for Injection, USP DRUG DESCRIPTION What are the possible side effects of thiopental (Pentothal)? You will remain under constant supervision during treatment with thiopental....
Read More  |  Review This
Reviews Multiple Electrolytes and Dextrose Injection

Plasma-Lyte M and 5% Dextrose Injection Drug Description PLASMA-LYTE M AND DEXTROSE (dextrose hydrous, sodium chloride, potassium chloride, magnesium chloride, sodium acetate trihydrate, sodium lactate and calcium chloride) injection,...
Read More  |  Review This
Reviews Zestoretic

Zestoretic Drug Description ZESTORETIC® (lisinopril and hydrochlorothiazide) USE IN PREGNANCY When used in pregnancy during the second and third trimesters, ACE inhibitors can cause injury and even death to the developing fetus....
Read More  |  Review This
Reviews Cutivate Lotion

Cutivate Lotion Drug Description CUTIVATE® (fluticasone propionate) Lotion, 0.05% For Topical Use Only. Not for Ophthalmic, Oral, or Intravaginal Use. DRUG DESCRIPTION What are the possible side effects of fluticasone topical...
Read More  |  Review This
Reviews Ethiodized Oil

Ethiodol Drug Description ETHIODOL (ethiodized oil) Injection A Low Viscosity Radio-Opaque Diagnostic Agent NOT FOR INTRAVASCULAR, INTRATHECAL OR INTRABRONCHIAL USE DRUG DESCRIPTION Ethiodol, brand of ethiodized oil, is a sterile injectable radio-...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....